{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T16:07:30Z","timestamp":1784304450624,"version":"3.55.0"},"reference-count":51,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,4,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:sec><jats:title>\u2003<\/jats:title><jats:p>Pregnancy-associated osteoporosis (PAO) is a rare, idiopathic disorder that usually presents with vertebral compression fractures (VCFs) within 6 months of a first pregnancy and delivery. Spontaneous improvement is typical. There is no known genetic basis for PAO. A 26-year-old primagravida with a neonatal history of unilateral blindness attributable to hyperplastic primary vitreous sustained postpartum VCFs consistent with PAO. Her low bone mineral density (BMD) seemed to respond to vitamin D and calcium therapy, with no fractures after her next successful pregnancy. Investigation of subsequent fetal losses revealed homozygosity for the methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism associated both with fetal loss and with osteoporosis (OP). Because her neonatal unilateral blindness and OP were suggestive of loss-of-function mutation(s) in the gene that encodes LDL receptor-related protein 5 (LRP5), LRP5 exon and splice site sequencing was also performed. This revealed a unique heterozygous 12-bp deletion in exon 21 (c.4454_4465del, p.1485_1488del SSSS) in the patient, her mother and sons, but not her father or brother. Her mother had a normal BMD, no history of fractures, PAO, ophthalmopathy, or fetal loss. Her two sons had no ophthalmopathy and no skeletal issues. Her osteoporotic father (with a family history of blindness) and brother had low BMDs first documented at ages \u223c40 and 32 years, respectively. Serum biochemical and bone turnover studies were unremarkable in all subjects. We postulate that our patient's heterozygous LRP5 mutation together with her homozygous MTHFR polymorphism likely predisposed her to low peak BMD. However, OP did not cosegregate in her family with the LRP5 mutation, the homozygous MTHFR polymorphism, or even the combination of the two, implicating additional genetic or nongenetic factors in her PAO. Nevertheless, exploration for potential genetic contributions to PAO may explain part of the pathogenesis of this enigmatic disorder and identify some at-risk women. \u00a9 2013 American Society for Bone and Mineral Research.<\/jats:p><\/jats:sec>","DOI":"10.1002\/jbmr.2095","type":"journal-article","created":{"date-parts":[[2013,9,7]],"date-time":"2013-09-07T10:08:57Z","timestamp":1378548537000},"page":"922-928","source":"Crossref","is-referenced-by-count":28,"title":["Pregnancy-Associated Osteoporosis With a Heterozygous Deactivating LDL Receptor-Related Protein 5 (<i>LRP5<\/i>) Mutation and a Homozygous Methylenetetrahydrofolate Reductase (<i>MTHFR<\/i>) Polymorphism"],"prefix":"10.1093","volume":"29","author":[{"given":"Fiona J","family":"Cook","sequence":"first","affiliation":[{"name":"Division of EndocrinologyBrody School of MedicineGreenvilleNCUSA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Mumm","sequence":"additional","affiliation":[{"name":"Division of Bone and Mineral DiseasesWashington University School of Medicine at Barnes-Jewish HospitalSt. LouisMOUSA"},{"name":"Center for Metabolic Bone Disease and Molecular ResearchShriners Hospital for ChildrenSt. LouisMOUSA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael P","family":"Whyte","sequence":"additional","affiliation":[{"name":"Division of Bone and Mineral DiseasesWashington University School of Medicine at Barnes-Jewish HospitalSt. LouisMOUSA"},{"name":"Center for Metabolic Bone Disease and Molecular ResearchShriners Hospital for ChildrenSt. LouisMOUSA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Wenkert","sequence":"additional","affiliation":[{"name":"Center for Metabolic Bone Disease and Molecular ResearchShriners Hospital for ChildrenSt. LouisMOUSA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2013,9,7]]},"reference":[{"key":"2024020318543588200_jbmr2095-bib-0001","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1210\/edrv.23.3.0464","article-title":"Genetics of osteoporosis","volume":"23","author":"Peacock","year":"2002","journal-title":"Endocr Rev."},{"key":"2024020318543588200_jbmr2095-bib-0002","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1056\/NEJM199503233321202","article-title":"Risk factors for hip fracture in white women. Study of Osteoporotic Fractures Research Group","volume":"332","author":"Cummings","year":"1995","journal-title":"N Engl J Med."},{"key":"2024020318543588200_jbmr2095-bib-0003","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s00198-004-1640-3","article-title":"Smoking and fracture risk: a meta analysis","volume":"16","author":"Kanis","year":"2005","journal-title":"Osteoporos Int."},{"key":"2024020318543588200_jbmr2095-bib-0004","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/B978-012470862-4\/50065-9","volume-title":"Osteoporosis","author":"Heaney","year":"2001","edition":"2nd ed"},{"issue":"22","key":"2024020318543588200_jbmr2095-bib-0005","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1056\/NEJMoa0801197","article-title":"Multiple genetic loci for bone mineral density and fractures","volume":"358","author":"Styrkarsdottir","year":"2008","journal-title":"N Engl J Med."},{"key":"2024020318543588200_jbmr2095-bib-0006","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.cell.2008.09.059","article-title":"LRP5 controls bone formation by inhibiting serotonin synthesis in the duodenum","volume":"135","author":"Yadav","year":"2008","journal-title":"Cell."},{"key":"2024020318543588200_jbmr2095-bib-0007","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ecl.2005.09.004","article-title":"Calcium and bone disorders during pregnancy and lactation","volume":"35","author":"Kovacs","year":"2006","journal-title":"Endocrinol Metab Clin N Am."},{"issue":"6","key":"2024020318543588200_jbmr2095-bib-0008","first-page":"2344","article-title":"Calcium and bone metabolism in pregnancy and lactation","volume":"86","author":"Kovacs","year":"2001","journal-title":"J Clin Endocrinol Metab."},{"key":"2024020318543588200_jbmr2095-bib-0009","first-page":"832","article-title":"Maternal-fetal calcium and bone metabolism during pregnancy, puerperium, and lactation","volume":"18","author":"Kovacs","year":"1997","journal-title":"Endocr Rev."},{"key":"2024020318543588200_jbmr2095-bib-0010","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1093\/ajcn\/88.4.1032","article-title":"Changes in bone mineral status and bone size during pregnancy and the influences of body weight and calcium intake","volume":"88","author":"Olausson","year":"2008","journal-title":"Am J Clin Nutr."},{"key":"2024020318543588200_jbmr2095-bib-0011"},{"key":"2024020318543588200_jbmr2095-bib-0012","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S0092-8674(01)00571-2","article-title":"LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development","volume":"107","author":"Gong","year":"2001","journal-title":"Cell."},{"key":"2024020318543588200_jbmr2095-bib-0013","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1359\/JBMR.050101","article-title":"Heterozygous mutations in the LDL receptor-related protein 5 (LRP5) gene are associated with primary osteoporosis in children","volume":"20","author":"Hartikka","year":"2005","journal-title":"J Bone Miner Res."},{"key":"2024020318543588200_jbmr2095-bib-0014","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1359\/JBMR.040704","article-title":"Influence of LRP5 polymorphisms on normal variation in BMD","volume":"19","author":"Koay","year":"2004","journal-title":"J Bone Miner Res."},{"key":"2024020318543588200_jbmr2095-bib-0015","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1359\/JBMR.050904","article-title":"Common genetic variation of the low-density lipoprotein receptor-related protein 5 and 6 genes determines fracture risk in elderly white men","volume":"21","author":"van Meurs","year":"2006","journal-title":"J Bone Miner Res."},{"key":"2024020318543588200_jbmr2095-bib-0016","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1359\/jbmr.060808","article-title":"Robust and comprehensive analysis of 20 osteoporosis candidate genes by very high-density single-nucleotide polymorphism screen among 405 white nuclear families identified significant association and gene-gene interaction","volume":"21","author":"Xiong","year":"2006","journal-title":"J Bone Miner Res."},{"key":"2024020318543588200_jbmr2095-bib-0017","doi-asserted-by":"crossref","first-page":"528","DOI":"10.7326\/0003-4819-151-8-200910200-00006","article-title":"Genetic Factors for Osteoporosis Consortium. Collaborative meta-analysis: associations of 150 candidate genes with osteoporosis and osteoporotic fracture","volume":"151","author":"Richards","year":"2009","journal-title":"Ann Intern Med."},{"key":"2024020318543588200_jbmr2095-bib-0018","doi-asserted-by":"crossref","first-page":"E1958","DOI":"10.1210\/jc.2012-1890","article-title":"Clinical review: genome wide association studies of skeletal phenotypes: what we have learned and where we are headed","volume":"97","author":"Hsu","year":"2012","journal-title":"J Clin Endocrinol Metab."},{"key":"2024020318543588200_jbmr2095-bib-0019","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1359\/JBMR.041223","article-title":"Oropharyngeal skeletal disease accompanying high bone mass and novel LRP5 mutation","volume":"20","author":"Rickels","year":"2005","journal-title":"J Bone Miner Res."},{"issue":"2","key":"2024020318543588200_jbmr2095-bib-0020","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1477-7827-2-7","article-title":"Methylenetetrahydrofolate reductase and transcobalamin genetic polymorphisms in human spontaneous abortion: biological and clinical implications","volume":"17","author":"Zetterberg","year":"2004","journal-title":"Reprod Biol Endocrinol."},{"key":"2024020318543588200_jbmr2095-bib-0021","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1056\/NEJMoa032546","article-title":"Homocysteine levels and the risk of osteoporotic fracture","volume":"350","author":"van Meurs","year":"2004","journal-title":"N Engl J Med."},{"key":"2024020318543588200_jbmr2095-bib-0022","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1056\/NEJMoa032739","article-title":"Homocysteine as a predictive factor for hip fracture in older persons","volume":"350","author":"McLean","year":"2004","journal-title":"N Engl J Med."},{"key":"2024020318543588200_jbmr2095-bib-0023","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1359\/jbmr.070210","article-title":"Plasma homocysteine, folate, and vitamin B 12 and the risk of hip fracture: the Hordaland Homocysteine Study","volume":"22","author":"Gjesdal","year":"2007","journal-title":"J Bone Miner Res."},{"key":"2024020318543588200_jbmr2095-bib-0024","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1007\/s00774-008-0878-9","article-title":"The synergistic effect of bone mineral density and methylenetetrahydrofolate reductase (MTHFR) polymorphism (C677T) on fractures","volume":"26","author":"Shiraki","year":"2008","journal-title":"J Bone Miner Metab."},{"key":"2024020318543588200_jbmr2095-bib-0025","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1359\/jbmr.070812","article-title":"Low dietary riboflavin but not folate predicts increased fracture risk in postmenopausal women homozygous for the MTHFR 677 T allele","volume":"23","author":"Yazdanpanah","year":"2008","journal-title":"J Bone Miner Res."},{"key":"2024020318543588200_jbmr2095-bib-0026","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.bone.2006.09.031","article-title":"Association of the methylenetetrahydrofolate reductase C677T polymorphism and fracture risk in Chinese postmenopausal women","volume":"40","author":"Hong","year":"2007","journal-title":"Bone."},{"key":"2024020318543588200_jbmr2095-bib-0027","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s00198-004-1704-4","article-title":"Methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism is associated with osteoporotic vertebral fractures, but is a weak predictor of BMD","volume":"16","author":"Villadsen","year":"2005","journal-title":"Osteoporos Int."},{"key":"2024020318543588200_jbmr2095-bib-0028","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/s00198-003-1584-z","article-title":"Evidence for an association of methylene tetrahydrofolate reductase polymorphism C677T and an increased risk of fractures: results from a population-based Danish twin study","volume":"15","author":"Bathum","year":"2004","journal-title":"Osteoporos Int."},{"key":"2024020318543588200_jbmr2095-bib-0029","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1359\/jbmr.2003.18.4.723","article-title":"A common methylenetetrahydrofolate reductase (C677T) polymorphism is associated with low bone mineral density and increased fracture incidence after menopause: longitudinal data from the Danish osteoporosis prevention study","volume":"18","author":"Abrahamsen","year":"2003","journal-title":"J Bone Miner Res."},{"key":"2024020318543588200_jbmr2095-bib-0030","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.bone.2005.08.005","article-title":"MTHFR c.677C &gt; T polymorphism as an independent predictor of peak bone mass in Danish men\u2014results from the Odense Androgen Study","volume":"38","author":"Abrahamsen","year":"2006","journal-title":"Bone."},{"key":"2024020318543588200_jbmr2095-bib-0031","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.bone.2004.12.014","article-title":"Are effects of MTHFR (C677T) genotype on BMD confined to women with low folate and riboflavin intake? Analysis of food records from the Danish osteoporosis prevention study","volume":"36","author":"Abrahamsen","year":"2005","journal-title":"Bone."},{"key":"2024020318543588200_jbmr2095-bib-0032","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1136\/jmg.40.8.619","article-title":"Geographical and ethnic variation of the 677C &gt; T allele of 5,10 methylenetetrahydrofolate reductase (MTHFR): findings from over 7000 newborns from 16 areas world wide","volume":"40","author":"Wilcken","year":"2003","journal-title":"J Med Genet."},{"issue":"216","key":"2024020318543588200_jbmr2095-bib-0033","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0378-1119(98)00311-4","article-title":"Cloning of a novel member of the low-density lipoprotein receptor family","author":"Hey","year":"1998","journal-title":"Gene."},{"key":"2024020318543588200_jbmr2095-bib-0034","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/BF01623007","article-title":"Osteoporosis in pregnancy","volume":"6","author":"Khovidhunkit","year":"1996","journal-title":"Osteoporos Int."},{"issue":"12","key":"2024020318543588200_jbmr2095-bib-0035","first-page":"865","article-title":"Pregnancy-associated osteoporosis","volume":"88","author":"Smith","year":"1995","journal-title":"QJM."},{"key":"2024020318543588200_jbmr2095-bib-0036","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s001980070113","article-title":"Pregnancy-associated osteoporosis: does the skeleton recover","volume":"11","author":"Phillips","year":"2000","journal-title":"Osteoporos Int."},{"key":"2024020318543588200_jbmr2095-bib-0037","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/BF00316284","article-title":"Bone mineral density and bone histomorphometric assessments of postpregnancy osteoporosis: a report of five patients","volume":"54","author":"Yamamoto","year":"1994","journal-title":"Calcif Tissue Int."},{"key":"2024020318543588200_jbmr2095-bib-0038","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1359\/JBMR.040816","article-title":"LRP5 and Wnt signaling; a union made for bone","volume":"19","author":"Johnson","year":"2004","journal-title":"J Bone Miner Res."},{"key":"2024020318543588200_jbmr2095-bib-0039","first-page":"52","article-title":"Ng KW","volume":"310","author":"Milat","year":"2009","journal-title":"Is Wnt signaling the final common pathway leading to bone formation? Mol Cell Endocrinol."},{"issue":"6","key":"2024020318543588200_jbmr2095-bib-0040","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1038\/nm.2388","article-title":"Lrp 5 functions in bone to regulate bone mass","volume":"17","author":"Cui","year":"2011","journal-title":"Nat Med."},{"key":"2024020318543588200_jbmr2095-bib-0041","first-page":"419","article-title":"Decreased bone density in carriers and patients of an Israeli family with the osteoporosis-pseudoglioma syndrome","volume":"5","author":"Lev","year":"2003","journal-title":"Isr Med Assoc J."},{"key":"2024020318543588200_jbmr2095-bib-0042","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1471-2350-13-26","article-title":"Mutations in LRP5 cause primary osteoporosis without features of OI by reducing Wnt signaling activity","volume":"13","author":"Korvala","year":"2012","journal-title":"BMC Med Genet."},{"key":"2024020318543588200_jbmr2095-bib-0043","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1007\/s00774-005-0676-6","article-title":"Assessment of linkage and association of 13 genetic loci with bone mineral density","volume":"24","author":"Lau","year":"2006","journal-title":"J Bone Miner Metab."},{"key":"2024020318543588200_jbmr2095-bib-0044","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1086\/425080","article-title":"Familial exudative vitreoretinopathy can also be associated with recessive mutations in LRP5","volume":"75","author":"Jiao","year":"2004","journal-title":"Am J Hum Genet."},{"key":"2024020318543588200_jbmr2095-bib-0045","doi-asserted-by":"crossref","first-page":"e7930","DOI":"10.1371\/journal.pone.0007930","article-title":"LRP4, a novel receptor for Dickkopf 1 and sclerostin, is expressed by osteoblasts and regulates bone growth and turnover in vivo","volume":"4","author":"Choi","year":"2009","journal-title":"PLoS One."},{"key":"2024020318543588200_jbmr2095-bib-0046","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1359\/jbmr.081235","article-title":"Where Wnts went: the exploding field of LRP5 and LRP6 signaling in bone","volume":"24","author":"Williams","year":"2009","journal-title":"J Bone Miner Res."},{"key":"2024020318543588200_jbmr2095-bib-0047","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1359\/JBMR.0301261","article-title":"Association of a common polymorphism in the methylenetetrahydrofolate reductase (MTHFR) gene with bone phenotypes depends on plasma folate status","volume":"19","author":"McLean","year":"2004","journal-title":"J Bone Miner Res."},{"key":"2024020318543588200_jbmr2095-bib-0048","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/ng0595-111","article-title":"A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase","volume":"10","author":"Frosst","year":"1995","journal-title":"Nat Genet."},{"key":"2024020318543588200_jbmr2095-bib-0049","first-page":"174","article-title":"Determinants and vitamin responsiveness of intermediate hyperhomocysteinemia (&gt; or = 40 micromol\/liter)","volume":"98","author":"Guttormsen","year":"1996","journal-title":"The Hordaland Homocysteine Study. J Clin Invest."},{"issue":"1","key":"2024020318543588200_jbmr2095-bib-0050","first-page":"203","article-title":"ACOG Practice Bulletin. Clinical management guidelines for obstetrician-gynecologists","volume":"102","year":"2003","journal-title":"Obstet Gynecol."},{"key":"2024020318543588200_jbmr2095-bib-0051","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/j.1365-2265.1993.tb02398.x","article-title":"Pregnancy associated osteoporosis","volume":"39","author":"Dunne","year":"1993","journal-title":"Clin Endocrinol."}],"container-title":["Journal of Bone and Mineral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fjbmr.2095","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/29\/4\/922\/56565722\/jbmr2095.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/29\/4\/922\/56565722\/jbmr2095.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T14:28:17Z","timestamp":1746023297000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jbmr\/article\/29\/4\/922-928\/7598945"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4,1]]},"references-count":51,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2013,9,7]]},"published-print":{"date-parts":[[2013,4,1]]}},"URL":"https:\/\/doi.org\/10.1002\/jbmr.2095","relation":{},"ISSN":["0884-0431","1523-4681"],"issn-type":[{"value":"0884-0431","type":"print"},{"value":"1523-4681","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2013,4,1]]},"published":{"date-parts":[[2013,4,1]]}}}